63sats Cybertech Limited
Frequently asked questions
Common questions on 63sats Cybertech Limited—tap a row to read the answer.
Q.1What is the latest 63SATS Cybertech unlisted share price?
The 63SATS Cybertech unlisted share price changes based on market demand, supply, and available transactions. Contact Dhankirti Wealth for the latest price and live market updates.
Q.2Has 63SATS Cybertech announced its IPO?
No. As of now, the company has not made any official announcement regarding its IPO.
Q.3What businesses does 63SATS Cybertech operate in?
The company operates across three major verticals:
CSF: Enterprise cybersecurity solutions
Cyberdome: Cybersecurity for government and critical infrastructure
CYBX: Consumer cybersecurity platform with cyber insurance benefits
Q.4What are the company's recent financial highlights?
63SATS Cybertech reported significant growth, with revenue increasing from ₹3.6 crore in FY25 to ₹87 crore in FY26. The company has also set a FY27 revenue target of ₹350 crore.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.
APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.
NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.
APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.
NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.
ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.
NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.